Literature DB >> 10645921

Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy. Importance of chamber size and systolic wall stress.

S C Smart1, T Knickelbine, F Malik, K B Sagar.   

Abstract

BACKGROUND: Left ventricular hypertrophy is a heterogeneous disorder with distinct morphologies. Changes in wall thickness, left ventricular chamber diameter, and mass alter systolic wall stress of the left ventricle and may influence ischemic threshold. Thus, the goal of this study was to investigate the effect of the different patterns of left ventricular hypertrophy on the accuracy of dobutamine-atropine stress echocardiography. METHODS AND
RESULTS: Three-hundred eighty-six patients underwent multistage dobutamine-atropine stress echocardiography and diagnostic angiography. Echocardiograms were measured for mean and relative wall thicknesses, chamber size, left ventricular mass, and end-systolic wall stress. The patterns of ventricular hypertrophy were concentric hypertrophy (increased wall thickness and mass), eccentric hypertrophy (normal wall thickness and increased mass), and concentric remodeling (increased wall thickness and normal mass). The overall sensitivity, specificity, and accuracy of dobutamine-atropine stress echocardiography for the detection of coronary artery disease were 85%, 87%, and 86%, respectively. Increased left ventricular mass index alone did not affect accuracy. Sensitivity was markedly reduced (36%) only in those with concentric remodeling. The univariate predictors of false-negative studies were single-vessel left circumflex disease, increased wall thickness, small chamber size, hyperdynamic ejection fraction, and left ventricular concentric remodeling. Multivariate predictors were concentric remodeling (P<0.0001; odds ratio, 13.5), left ventricular ejection fraction >2 SD above normal (P<0.0001), and single-vessel left circumflex disease (P<0.0007; odds ratio, 7.6). Sensitivity was excellent in patients with small ventricles and normal wall thickness and in those with normal or large chambers regardless of wall thickness.
CONCLUSIONS: Dobutamine-atropine stress echocardiography is an accurate test in most patients with left ventricular hypertrophy, but it is insensitive in the small subset with concentric remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10645921     DOI: 10.1161/01.cir.101.3.258

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Stress echocardiography in the diagnosis of coronary artery disease.

Authors:  W Mazur; S F Nagueh
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

2.  Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy.

Authors:  Abdou Elhendy; Arend F L Schinkel; Ron T van Domburg; Jeroen J Bax; Harm H H Feringa; Peter G Noordzij; Olaf Schouten; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 3.  Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography.

Authors:  R Senior; M Monaghan; H Becher; J Mayet; P Nihoyannopoulos
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

5.  Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis.

Authors:  Paola Gargiulo; Mario Petretta; Dario Bruzzese; Alberto Cuocolo; Maria Prastaro; Carmen D'Amore; Enrico Vassallo; Gianluigi Savarese; Caterina Marciano; Stefania Paolillo; Pasquale Perrone Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-04       Impact factor: 9.236

6.  Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing.

Authors:  Charaslak Charoenpanichkit; Timothy M Morgan; Craig A Hamilton; Eric L Wallace; Killian Robinson; William O Ntim; W Gregory Hundley
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-04       Impact factor: 7.792

7.  Estimating Myocardial Motion by 4D Image Warping.

Authors:  Hari Sundar; Harold Litt; Dinggang Shen
Journal:  Pattern Recognit       Date:  2009-11-01       Impact factor: 7.740

8.  Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation.

Authors:  Vanji Karthikeyan; Karthik Ananthasubramaniam
Journal:  Curr Cardiol Rev       Date:  2009-08

9.  Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

10.  Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.

Authors:  Thomas F Walsh; Erica Dall'Armellina; Haroon Chughtai; Timothy M Morgan; William Ntim; Kerry M Link; Craig A Hamilton; Dalane W Kitzman; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-03       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.